Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

EUSA raises over $50mm to fund acquisition

Executive Summary

Specialty pharmaceuticals company EUSA Pharma (focuses on cancer and pain control) raised over $50mm through a private financing that was led by TVM Capital and included participation from existing backers Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed, and NovaQuest. The company will use the proceeds to finance its recently announced acquisition of Cytogen, a public company that also develops and sell products for the oncology and pain markets. Completion of the financing is contingent upon the closing of the acquisition.

Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies